Approach to Sleep Disordered Breathing in Children
For otherwise healthy children with sleep disordered breathing and adenotonsillar hypertrophy, adenotonsillectomy is the first-line definitive treatment, but clinicians must recognize that success rates are highly variable—ranging from 80% in younger, normal-weight children to less than 50% in obese children—and families must be counseled that additional interventions may be necessary. 1
Initial Diagnostic Evaluation
When to Obtain Polysomnography (PSG)
Mandatory PSG before surgery: 1
- Children with obesity
- Down syndrome
- Craniofacial abnormalities
- Neuromuscular disorders
- Sickle cell disease
- Mucopolysaccharidoses
Consider PSG when: 1
- Need for surgery is uncertain
- Discordance between tonsillar size on examination and reported severity of symptoms
- Parents desire confirmation of diagnosis
PSG may be omitted: 1
- Otherwise healthy child with strong history of struggling to breathe
- Daytime symptoms present
- Enlarged tonsils on examination
- No comorbidities
Clinical Assessment Focus
Look specifically for: 1
- Tonsillar size and degree of obstruction
- Body mass index and obesity status
- Ethnicity (African American children have lower cure rates)
- Age (younger children have better outcomes)
- Severity of OSA symptoms
- Presence of chronic rhinitis or deviated nasal septum 2
Primary Treatment: Adenotonsillectomy
Expected Success Rates
Younger, normal-weight, non-African American children: 80% resolution 1, 3
Obese children: Less than 50% complete resolution 1, 3
Overall success rate (AHI <2 events/hour): 79% based on the CHAT trial 1
Complete cure rates: Only 27-40% in some populations 3
Predictors of Treatment Failure
Children at higher risk for persistent OSA after surgery: 3, 2
- Age greater than 7 years
- Obesity (50% prevalence of persistent OSA)
- Baseline severe OSA (AHI >10/hour)
- African American ethnicity
- Chronic rhinitis
- Deviated nasal septum
- Small tonsil size despite symptoms
- Underlying genetic or metabolic disorders
Perioperative Management
Communicate PSG results to anesthesiologist before surgery 1
Admit for overnight monitoring if: 1
- Age younger than 3 years
- Severe OSA on PSG (AHI ≥10 events/hour)
- Oxygen saturation nadir <80%
Management of Persistent or Recurrent OSA
Approximately 30-73% of children will have residual OSA after adenotonsillectomy, making post-operative assessment critical. 3
Post-Operative Evaluation
- Children with persistent snoring or symptoms
- High-risk patients (obese, older age, severe pre-operative OSA, comorbidities)
- Those with severely abnormal preoperative PSG
Second-Line Interventions
For persistent OSA, evaluate and treat: 4, 3
Lingual tonsillar hypertrophy - Consider lingual tonsillectomy if identified 4
Weight management - Mandatory for overweight/obese children 1, 4, 3
CPAP therapy - For children who don't qualify for site-specific upper airway treatment 1, 4, 3
Medical management: 5
- Nasal steroids for mild to moderate OSA
- Leukotriene receptor antagonists for mild to moderate OSA
- Treatment of chronic rhinitis
Orthodontic intervention - Rapid maxillary expansion if specific craniofacial features present 4, 5
Special Populations
Obese children: 1
- CPAP may be reasonable alternative to surgery as first-line treatment
- Tonsillectomy often leads to weight gain, potentially worsening OSA
- Multimodal approach typically required
Children with Down syndrome or mucopolysaccharidoses: 6
- Adenotonsillectomy and CPAP appear equally effective based on limited evidence
Critical Counseling Points
Families must understand before surgery: 1
Enlarged tonsils are the most common but not sole cause of OSA—muscle tone plays a role 1
Obesity is a major independent contributor 1
Surgery success varies by age, weight, ethnicity, OSA severity, and medical conditions 1
Additional interventions may be necessary including weight loss, medications, CPAP, or further surgery 1, 3
OSA may persist or recur after surgery 1
Document this counseling in the medical record 1
Common Pitfalls to Avoid
- Assuming tonsillectomy will completely resolve OSA in all children 3
- Failing to obtain PSG in high-risk populations before surgery 1
- Not considering post-operative PSG in children with persistent symptoms or risk factors 1, 3
- Overlooking weight gain after tonsillectomy as a contributor to residual OSA 1
- Ignoring non-tonsillar factors (muscle tone, obesity, craniofacial anatomy) 1
- Not addressing chronic rhinitis or nasal obstruction as contributing factors 2